Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for biomarkers that have been shown to play key roles in […]

Agreement Accelerates the Development of Tests to Help Assess Risk of Disease Recurrence in Women with Early-Stage Breast Cancer SANTA CLARA, Calif. & IRVINE, Calif.–Agilent Technologies Inc. (NYSE: A) and Agendia, Inc. today jointly announced an agreement to expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint […]

Omaha, NE – Streck, Inc. and Nordic BioSite, a life sciences products distributor in Sweden, Finland, Denmark and Norway, have signed a distribution agreement for Streck’s full portfolio of cell stabilization, molecular and core products. Streck’s cell stabilization products include Cell-Free DNA Urine Preserve, a formaldehyde-free liquid reagent that stabilizes cell-free DNA (cfDNA) in urine; […]

Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, today announced its G:BOX Chemi XX6 multi-application imager is being utilised by scientists at a top University in Germany to speed up analysis of genes and proteins associated with neurodegenerative conditions. Researchers at the German University are using a G:BOX Chemi XX6 multi-application imager to […]

Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, today announced that it has signed an agreement to be acquired by Sysmex Corporation (Sysmex), a Japanese in vitro diagnostic company. Sysmex will acquire all of OGT’s shares, gaining access to OGT’s genetic analysis technologies and expertise in the cytogenetics domain. OGT will become a […]

Key Executive to Drive the Commercialization of Next Generation Biotechnology Instrumentation for Drug Discovery and Development BURLINGTON, Mass. — RedShift BioAnalytics, Inc., an innovative provider of bioanalytical instrumentation for the research, development and manufacturing of protein therapeutic drugs, recently announced the hiring of Jeffrey Zondermanas Chief Commercial Officer. Jeff brings over 25 years of experience […]

PORTLAND, OR and CAMBRIDGE, MA— MolecularMD Corp., a molecular diagnostics company that provides  clinical trial services and development of companion diagnostics for targeted and immunotherapies in oncology, is now recognized as a Certified Service Provider of ArcherDX next-generation sequencing (NGS) panels, adding to MolecularMD’s NGS Advanced Diagnostics service offering. The agreement solidifies MolecularMD as a […]

WINOOSKI VT, USA — BioTek Instruments introduces theCytation™ 1 Cell Imaging Multi-Mode Reader as an affordable entry into automated digital quantitative microscopy along with multi-mode microplate detection. This patented combined solution provides quantitative phenotypic cellular information and well-based quantitative data, while the modular architecture allows users to satisfy their current research needs, and upgrade with […]

-Expanding Our Portfolio and Reinforcing Our Technology Base in the Life Science Business- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has reached an agreement with Oxford Gene Technology IP Limited (HQ: Oxfordshire county, United Kingdom; CEO: Michael Evans; “OGT”) to acquire all shares in OGT (the “Acquisition”). Through this move, Sysmex aims […]